Product was successfully added to your shopping cart.
Free Shipping Over $49
Call Now! 877-847-7389
0item(s)

You have no items in your shopping cart.

  • EloxiOral EloxiOral
  • EloxiOral 10mL EloxiOral 10mL
  • EloxiOral 32mL EloxiOral 32mL
  • EloxiOral 100mL EloxiOral 100mL

EloxiOral Suspension (Generic Meloxicam)

by Henry Schein

4.4 5

* Required Fields

$18.99

This product requires a veterinarian's prescription.

This Rx product can not be shipped to some states.

Details

Benefits:

  • less expensive than Meloxicam
  • indicated for the control of pain and inflammation associated with osteoarthritis in dogs
  • May be either mixed with food or placed directly into the mouth
  • EloxiOral is packaged with 2 sizes of dosing syringes. The small syringe is calibrated in 1 lb increments for use in dogs under 30 lbs, while the large syringe is calibrated in 5 lb increments (up to 160 lbs) and should be used for dosing dogs that are 30 lbs and over. This enables the 1.5 mg/mL strength to be easily and conveniently used on small dogs, eliminating the need for stocking a 0.5 mg/mL meloxicam.

Contraindications

Dogs with known hypersensitivity to meloxicam should not receive EloxiOral Oral Suspension. Do not use EloxiOral Oral Suspension in cats. Acute renal failure and death have been associated with the use of meloxicam in cats.

Warnings

Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. For oral use in dogs only.

As with any NSAID all dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to and periodically during administration. Owner should be advised to observe their dog for signs of potential drug toxicity and be given a client information sheet about EloxiOral.

Precautions

The safe use of EloxiOral Oral Suspension in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated. Meloxicam is not recommended for use in dogs with bleeding disorders, as safety has not been established in dogs with these disorders. As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Sensitivity to drug-associated adverse events varies with the individual patient.

Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID. Patients at greatest risk for renal toxicity are those that are dehydrated, on concomitant diuretic therapy, or those with existing renal, cardiovascular, and/or hepatic dysfunction. Concurrent administration of potentially nephrotoxic drugs should be carefully approached. NSAIDs may inhibit the prostaglandins that maintain normal homeostatic function. Such anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease that has not been previously diagnosed. Since NSAIDs possess the potential to induce gastrointestinal ulcerations and/or perforations, concomitant use with other anti-inflammatory drugs, such as NSAIDs or corticosteroids, should be avoided. If additional pain medication is needed after administration of the total daily dose of EloxiOral Oral Suspension, a non-NSAID or non-corticosteroid class of analgesia should be considered. The use of another NSAID is not recommended. Consider appropriate washout times when switching from corticosteroid use or from one NSAID to another in dogs. The use of concomitantly protein-bound drugs with EloxiOral Oral Suspension has not been studied in dogs. Commonly used protein-bound drugs include cardiac, anticonvulsant and behavioral medications. The influence of concomitant drugs that may inhibit metabolism of EloxiOral Oral Suspension has not been evaluated. Drug compatibility should be monitored in patients requiring adjunctive therapy.

Adverse Reactions

Possible adverse reactions include 

Vomiting

 

 

Diarrhea/Soft Stool

 

 

Bloody Stool

 

 

Inappetance

 

 

Bleeding gums after dental procedure

 

 

Lethargy/Swollen Carpus

 

 

Epiphora

Contact your veterinarian if your pet shows signs of adverse reaction.

Instructions

It is important to follow your Veterinarian's prescription in structions for your pet.

Dosage and Administration

Always provide client information sheet with prescription. Carefully consider the potential benefits and risk of EloxiOral Oral Suspension and other treatment options before deciding to use EloxiOral Oral Suspension. Use the lowest effective dose for the shortest duration consistent with individual response. EloxiOral Oral Suspension should be administered initially at 0.09 mg/lb (0.2 mg/kg) body weight only on the first day of treatment. For all treatments after day 1, EloxiOral Oral Suspension should be administered once daily at a dose of 0.045 mg/lb (0.1 mg/kg). The syringes are calibrated to deliver the daily

maintenance dose in lbs. Because the first dose (0.2 mg/kg) is two times the amount of the daily maintenance dose (0.1 mg/kg), two syringes containing the 0.1 mg/kg dose should be administered at the first dose.

Directions for Administration:

EloxiOral Oral Suspension is packaged with 2 sizes of dosing syringes. The small syringe is calibrated in 1-lb increments for use in dogs under 30 lbs. The large syringe is calibrated in 5-lb increments (up to 160 lbs.) and should be used for dosing dogs that are 30 lbs and over. Only administer EloxiOral with the provided syringes. The container should never be used as a dropper bottle for administration of EloxiOral.

Dogs Under 30 Lbs (13.6 Kg)

Shake well before use, then remove cap. EloxiOral Oral Suspension can be given either mixed with food or placed directly into the mouth. Particular care should be given with regard to the accuracy of dosing. To prevent accidental overdosing of small dogs, only use the small dosing syringe. The large syringe provided should not be used to measure doses for dogs weighing less than 30 lbs (13.6 kg). For dogs under 30 lbs, use the small dosing syringe provided in the package (see dosing procedure below). The small dosing syringe fits onto the bottle and has dosing marks in 1-lb increments, designed to deliver the daily maintenance dose of 0.045 mg/lb (0.1 mg/kg). For dogs between 1 - 29 lbs, EloxiOral can be given using the marks on the small dosing syringe. When using the small dosing syringe, the dog’s weight should be rounded down to the nearest 1-lb increment. Replace and tighten cap after use.

Dogs 30 Lbs (13.6 Kg) And Over

Shake well before use, then remove cap. EloxiOral may be either mixed with food or placed directly into the mouth. Particular care should be given with regard to the accuracy of dosing. To prevent accidental overdosing of small dogs, do not use the large syringe in animals weighing less than 30 pounds. For dogs 30 lbs or greater, the large dosing syringe provided in the package should be used (see dosing procedure below). The large dosing syringe fits onto the bottle and has dosing marks in 5-lb increments (up to 160 lbs), designed to deliver the daily maintenance dose of 0.045 mg/lb (0.1 mg/kg). When using the large syringe, the dog’s weight should be rounded down to the nearest 5-lb increment. Replace and tighten cap after use.

Ingredients

Meloxicam - 1.5 mg/mL

Additional Information

Is Rx Product Yes

Free Shipping

Free Shipping

Need Help?

Need Help?

Read "Ask Dr. Barry"